Continuous biomanufacturing – Key drivers for adoption, economic modelling and regulatory considerations

Recent Posts

Cool Tool – Inline Diafiltration Closes the Gap for End-to-End Continuous Bioprocessing

Diafiltration, while fulfilling several functions in protein purification, has also presented a major obstacle in achieving continuous biomanufacturing. Technologies launched…

Start With the End in Mind – How to facilitate transfer from non-GMP to GMP Manufacturing

In this podcast and accompanying article, we interviewed Avril Vermunt, bioprocess hardware specialist at GE healthcare about transferring a process…

Modeling Downstream Disruptive Technologies to Improve Downstream Bioprocessing

In this podcast and accompanying article we interviewed Dr. Yuyi Shen, Principal Scientist, Grifols about the benefits of modeling downstream…

Downstream Column logo tall

Impurity Precipitation Strategies for Intensification of mAb Downstream Processes

Next month, CBI will host its Downstream Disruptive Technologies conference in San Diego. This conference promises to highlight exciting new…

Implementing Process Analytical Technology (PAT) in Continuous Bioprocessing

Continuous bioprocessing presents many exciting opportunities for improving biomanufacturing. Frequently discussed are methods for incorporating Process Analytical Technology (PAT) initiatives…

Video – Viral Safety in Biologics Manufacturing

Regulatory bodies have long recognized that viral safety in biologics manufacturing is a top priority. The presence of adventitious agents…

Our Sponsor

Sponsors and Media Partners

Platinum
Sponsor

GE Healthcare Life Sciences

Gold
Sponsor

JSR Life Sciences
Pall Biotech

Silver
Sponsor

BIA Separations
Kaneka
EMD Millipore + Sigma-Aldrich = MilliporeSigma
Purolite Life Sciences